Huntington’s disease is an inherited neurological disorder causing movement, cognitive, and behavioral issues. Effective management includes medical treatments, therapies, nutritional support, and ...

Huntington's disease (HD) is a hereditary neurodegenerative disorder ... The movement disorder is characterized by involuntary movements known as chorea, and by the impairment of voluntary movements.

such as jerking or twitching (chorea) difficulty with coordination trouble learning new information difficulty making decisions Juvenile and late onset forms of Huntington’s disease are also ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

The FDA has approved Austedo (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease (HD). Formerly known as SD-809, Austedo is the first drug containing ...

Looking for reliable medications to treat 'Huntington´s Disease'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Drug Significantly Reduces Chorea Symptoms in Patients With Huntington's Disease May 19, 2023 — The drug valbenazine statistically improves chorea, a movement disorder commonly associated with ...

University of Bergen researcher Markus Miettinen is among the first scientists to provide a detailed description of protein clumps associated with Huntington's disease. The findings, which could ...

University of Bergen researcher Markus Miettinen is among the first scientists to provide a detailed description of protein clumps associated with Huntington's disease. The findings, which could ...